Cargando…

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder

Autism spectrum disorder (ASD) affects ~ 2% of children in the United States. The etiology of ASD likely involves environmental factors triggering physiological abnormalities in genetically sensitive individuals. One of these major physiological abnormalities is mitochondrial dysfunction, which may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rose, Shannon, Niyazov, Dmitriy M., Rossignol, Daniel A., Goldenthal, Michael, Kahler, Stephen G., Frye, Richard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132446/ https://www.ncbi.nlm.nih.gov/pubmed/30039193 http://dx.doi.org/10.1007/s40291-018-0352-x

Ejemplares similares

The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder
por: Delhey, Leanna M., et al.
Publicado: (2017)

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
por: Rossignol, D A, et al.
Publicado: (2012)

A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder
por: Frye, Richard E, et al.
Publicado: (2022)

Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder
por: Frye, Richard Eugene, et al.
Publicado: (2014)

Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome
por: Frye, Richard E., et al.
Publicado: (2015)

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism
por: Rossignol, Daniel A., et al.
Publicado: (2014)

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
por: Rossignol, D A, et al.
Publicado: (2012)

Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes
por: Frye, Richard E., et al.
Publicado: (2016)

Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD)
por: Harville, Terry, et al.
Publicado: (2019)

Age-Related Changes in Epilepsy Characteristics and Response to Antiepileptic Treatment in Autism Spectrum Disorders
por: Gundogdu, Beliz Su, et al.
Publicado: (2023)

The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review
por: Rossignol, Daniel A., et al.
Publicado: (2014)

Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome
por: Frye, Richard E., et al.
Publicado: (2016)

Bioenergetic variation is related to autism symptomatology
por: Delhey, Leanna, et al.
Publicado: (2017)

The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021)

Metabolomic Signatures of Autism Spectrum Disorder
por: Brister, Danielle, et al.
Publicado: (2022)

Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2020)

Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment
por: Jyonouchi, Harumi, et al.
Publicado: (2022)

Environmental toxicants and autism spectrum disorders: a systematic review
por: Rossignol, D A, et al.
Publicado: (2014)

Variations in Mitochondrial Respiration Differ in IL-1ß/IL-10 Ratio Based Subgroups in Autism Spectrum Disorders
por: Jyonouchi, Harumi, et al.
Publicado: (2019)

Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
por: Frye, Richard E., et al.
Publicado: (2016)

A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
por: Rossignol, Daniel A, et al.
Publicado: (2021)

Mitochondrial morphology is associated with respiratory chain uncoupling in autism spectrum disorder
por: Frye, Richard E., et al.
Publicado: (2021)

Ratings of the Effectiveness of Nutraceuticals for Autism Spectrum Disorders: Results of a National Survey
por: Adams, James B., et al.
Publicado: (2021)

Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021)

Cerebral folate receptor autoantibodies in autism spectrum disorder
por: Frye, R E, et al.
Publicado: (2013)

Mitochondrial Dysfunction Is Inducible in Lymphoblastoid Cell Lines From Children With Autism and May Involve the TORC1 Pathway
por: Bennuri, Sirish C., et al.
Publicado: (2019)

Increased Susceptibility to Ethylmercury-Induced Mitochondrial Dysfunction in a Subset of Autism Lymphoblastoid Cell Lines
por: Rose, Shannon, et al.
Publicado: (2015)

Hyperbaric oxygen treatment in autism spectrum disorders
por: Rossignol, Daniel A, et al.
Publicado: (2012)

Prenatal air pollution influences neurodevelopment and behavior in autism spectrum disorder by modulating mitochondrial physiology
por: Frye, Richard E., et al.
Publicado: (2020)

Mitochondria May Mediate Prenatal Environmental Influences in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2021)

Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study
por: Rose, Shannon, et al.
Publicado: (2017)

Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder
por: Barone, Rita, et al.
Publicado: (2021)

The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment
por: Frye, Richard E., et al.
Publicado: (2022)

Editorial: Comorbidity and Autism Spectrum Disorder
por: Casanova, Manuel F., et al.
Publicado: (2020)

Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11, 1141
por: Rossignol, Daniel A., et al.
Publicado: (2022)

Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder
por: Frye, Richard E
Publicado: (2014)

A Personalized Multidisciplinary Approach to Evaluating and Treating Autism Spectrum Disorder
por: Frye, Richard E.
Publicado: (2022)

MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
por: Frye, Richard E., et al.
Publicado: (2021)

Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder
por: Frye, R E, et al.
Publicado: (2013)

Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism
por: Rose, Shannon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jaeu7vj1venltuq24kjnq3hl26